ResearcherXijing HospitalActive in the last 2 years

Xiaoliang Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9785-5237; OpenAlex author ID A5081626215. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Burden of pancreatic cancer among the Western Pacific Region and association with human resources for health from 1990 to 2021: Results from the Global Burden … Co-author DOI 10.21147/j.issn.1000-9604.2025.04.14 ↗
ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. Co-author DOI 10.1016/j.canlet.2021.09.026 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Daiming Fan · 1 shared paper, 2025 · strength 0.30
- Paper Burden of pancreatic cancer among the Western Pacific Region and association with human resources for health from 1990 … DOI 10.21147/j.issn.1000-9604.2025.04.14 ↗
Fei‐Long Ning · 1 shared paper, 2025 · strength 0.30
- Paper Burden of pancreatic cancer among the Western Pacific Region and association with human resources for health from 1990 … DOI 10.21147/j.issn.1000-9604.2025.04.14 ↗
Hao Liu · 1 shared paper, 2022 · strength 0.13
- Paper ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. DOI 10.1016/j.canlet.2021.09.026 ↗
Daiming Fan · 1 shared paper, 2022 · strength 0.13
- Paper ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. DOI 10.1016/j.canlet.2021.09.026 ↗
Weijie Wang · 1 shared paper, 2022 · strength 0.13
- Paper ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. DOI 10.1016/j.canlet.2021.09.026 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.